CTMX - CIK 0001501989
CytomX Therapeutics, Inc. has filed 773 documents with the SEC between 2010 and 2026. The most frequent type is insider trade (346 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-13 | - |
| Insider trade | 4 | 2024-01-19 | 2024-01-18 |
| Insider trade | 4 | 2024-01-19 | 2024-01-18 |
| Insider trade | 4 | 2024-01-19 | 2024-01-18 |
| Insider trade | 4 | 2024-01-19 | 2024-01-18 |
| Insider trade | 4 | 2024-01-19 | 2024-01-18 |
| Insider trade | 4 | 2024-01-19 | 2024-01-18 |
| Insider trade | 4 | 2023-12-22 | 2023-12-20 |
| Insider trade | 4 | 2023-12-22 | 2023-12-20 |
| Insider trade | 4 | 2023-12-22 | 2023-12-20 |
| Insider trade | 4 | 2023-12-22 | 2023-12-20 |
| Insider trade | 4 | 2023-12-22 | 2023-12-20 |
| Insider trade | 4 | 2023-12-19 | 2023-12-17 |
| Insider trade | 4 | 2023-12-19 | 2023-12-17 |
| Insider trade | 4 | 2023-12-19 | 2023-12-17 |
| Insider trade | 4 | 2023-12-19 | 2023-12-17 |
| Insider trade | 4 | 2023-12-19 | 2023-12-17 |
| Major company event | 8-K | 2023-11-07 | 2023-11-07 |
| Quarterly report | 10-Q | 2023-11-07 | 2023-09-30 |
| Insider trade | 4 | 2023-09-22 | 2023-09-20 |
| Insider trade | 4 | 2023-09-22 | 2023-09-20 |
| Insider trade | 4 | 2023-09-22 | 2023-09-20 |
| Insider trade | 4 | 2023-09-22 | 2023-09-20 |
| 424B3 | - | 2023-08-28 | - |
| EFFECT | - | 2023-08-25 | - |
| Major company event | 8-K | 2023-08-24 | 2023-08-08 |
| Company correspondence | CORRESP | 2023-08-23 | - |
| SEC correspondence | UPLOAD | 2023-08-22 | - |
| D | - | 2023-08-17 | - |
| Securities registration | S-3 | 2023-08-16 | - |
| Major company event | 8-K | 2023-08-08 | 2023-08-08 |
| Quarterly report | 10-Q | 2023-08-08 | 2023-06-30 |
| Insider trade | 4 | 2023-07-20 | 2023-07-19 |
| New insider ownership | 3 | 2023-07-20 | 2023-07-19 |
| Major company event | 8-K | 2023-07-03 | 2023-06-29 |
| Major company event | 8-K | 2023-06-20 | 2023-06-14 |
| Insider trade | 4 | 2023-06-16 | 2023-06-14 |
| Insider trade | 4 | 2023-06-16 | 2023-06-14 |
| Insider trade | 4 | 2023-06-16 | 2023-06-14 |
| Insider trade | 4 | 2023-06-16 | 2023-06-14 |
| Insider trade | 4 | 2023-06-16 | 2023-06-14 |
| Insider trade | 4 | 2023-06-16 | 2023-06-14 |
| Insider trade | 4 | 2023-05-23 | 2023-05-19 |
| Major company event | 8-K | 2023-05-09 | 2023-05-09 |
| Quarterly report | 10-Q | 2023-05-09 | 2023-03-31 |
| Proxy materials | DEFA14A | 2023-04-27 | - |
| Proxy statement | DEF 14A | 2023-04-27 | 2023-06-14 |
| Insider trade | 4 | 2023-03-31 | 2023-03-29 |